Who owns TRAVERE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Travere Therapeutics stock

Who bought or sold TRAVERE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Jpmorgan Chase & Co 445k $11M 4348% Sep 2025
 View chart
Simplex Trading 208k $5.0M 85% Sep 2025
 View chart
Exome Asset Management 110k $2.6M 0% Sep 2025
 View chart
IMC-Chicago 63k $1.5M 100% Sep 2025
 View chart
Group One Trading 56k $1.3M -78% Sep 2025
 View chart